Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Bone metastasis is the most frequent complication in prostate cancer patients and associated outcome remains fatal. Radium223 (Rad223), a bone targeting radioisotope improves overall survival in patients (3.6 months vs. placebo). | An agent-based model of prostate Cancer bone metastasis progression and response to Radium223